|
CH652145A5
(de)
|
1982-01-22 |
1985-10-31 |
Sandoz Ag |
Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
|
|
US4634666A
(en)
|
1984-01-06 |
1987-01-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Human-murine hybridoma fusion partner
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
EP0279582A3
(en)
|
1987-02-17 |
1989-10-18 |
Pharming B.V. |
Dna sequences to target proteins to the mammary gland for efficient secretion
|
|
AU600575B2
(en)
|
1987-03-18 |
1990-08-16 |
Sb2, Inc. |
Altered antibodies
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5633076A
(en)
|
1989-12-01 |
1997-05-27 |
Pharming Bv |
Method of producing a transgenic bovine or transgenic bovine embryo
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
ATE356869T1
(de)
|
1990-01-12 |
2007-04-15 |
Amgen Fremont Inc |
Bildung von xenogenen antikörpern
|
|
IE64738B1
(en)
|
1990-03-20 |
1995-09-06 |
Akzo Nv |
Stabilized gonadotropin containing preparations
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
DK0585287T3
(da)
|
1990-07-10 |
2000-04-17 |
Cambridge Antibody Tech |
Fremgangsmåde til fremstilling af specifikke bindingsparelementer
|
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
DK0546073T3
(da)
|
1990-08-29 |
1998-02-02 |
Genpharm Int |
Frembringelse og anvendelse af transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5871907A
(en)
|
1991-05-15 |
1999-02-16 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
US5858657A
(en)
|
1992-05-15 |
1999-01-12 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
ATE255131T1
(de)
|
1991-06-14 |
2003-12-15 |
Genentech Inc |
Humanisierter heregulin antikörper
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
CA2124967C
(en)
|
1991-12-17 |
2008-04-08 |
Nils Lonberg |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
DK1589107T3
(da)
|
1992-08-21 |
2010-04-26 |
Univ Bruxelles |
Immonuglobuliner uden lette kæder
|
|
EP0672142B1
(en)
|
1992-12-04 |
2001-02-28 |
Medical Research Council |
Multivalent and multispecific binding proteins, their manufacture and use
|
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
|
US5877218A
(en)
|
1994-01-10 |
1999-03-02 |
Teva Pharmaceutical Industries, Ltd. |
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
|
|
US5786464C1
(en)
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
|
AU695129B2
(en)
|
1995-02-06 |
1998-08-06 |
Genetics Institute, Llc |
Formulations for IL-12
|
|
DE19539493A1
(de)
|
1995-10-24 |
1997-04-30 |
Thomae Gmbh Dr K |
Starker homologer Promotor aus Hamster
|
|
US5834597A
(en)
|
1996-05-20 |
1998-11-10 |
Protein Design Labs, Inc. |
Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
|
|
US6114148C1
(en)
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
|
US5888809A
(en)
|
1997-05-01 |
1999-03-30 |
Icos Corporation |
Hamster EF-1α transcriptional regulatory DNA
|
|
CN1316055A
(zh)
*
|
1998-07-03 |
2001-10-03 |
基因创新有限公司 |
神经变性的鉴别诊断
|
|
MY128897A
(en)
|
1999-02-05 |
2007-02-28 |
Samsung Electronics Co Ltd |
Image texture retrieving method and apparatus thereof
|
|
TWI255272B
(en)
|
2000-12-06 |
2006-05-21 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
EP1539233B1
(en)
|
2001-07-12 |
2011-04-27 |
FOOTE, Jefferson |
Super humanized antibodies
|
|
WO2004039234A2
(en)
|
2002-05-13 |
2004-05-13 |
Alexion Pharmaceuticals, Inc. |
Humanized antibodies against the venezuelan equine encephalitis virus
|
|
US8506959B2
(en)
|
2002-11-01 |
2013-08-13 |
Neotope Biosciences Limited |
Prevention and treatment of synucleinopathic and amyloidogenic disease
|
|
TW200509968A
(en)
|
2002-11-01 |
2005-03-16 |
Elan Pharm Inc |
Prevention and treatment of synucleinopathic disease
|
|
US9034337B2
(en)
*
|
2003-10-31 |
2015-05-19 |
Prothena Biosciences Limited |
Treatment and delay of outset of synucleinopathic and amyloidogenic disease
|
|
US20080014194A1
(en)
|
2003-10-31 |
2008-01-17 |
Elan Pharmaceuticals, Inc. |
Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
|
|
WO2008103472A2
(en)
*
|
2007-02-23 |
2008-08-28 |
Elan Pharmaceuticals, Inc. |
Prevention and treatment of synucleinopathic and amyloidogenic disease
|
|
ES2293096T3
(es)
|
2002-11-29 |
2008-03-16 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
Nuevos genes de la fosfotransferasa de neomicina y procedimiento para la seleccion de celulas recombinantes de produccion elevada.
|
|
ES2609010T3
(es)
|
2003-04-04 |
2017-04-18 |
Genentech, Inc. |
Formulaciones de anticuerpos y de proteínas a concentración elevada
|
|
US7358331B2
(en)
|
2003-05-19 |
2008-04-15 |
Elan Pharmaceuticals, Inc. |
Truncated fragments of alpha-synuclein in Lewy body disease
|
|
DE10338531A1
(de)
|
2003-08-19 |
2005-04-07 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Reklonierung von Produktionszellen
|
|
US7674599B2
(en)
|
2003-11-08 |
2010-03-09 |
Elan Pharmaceuticals, Inc. |
Methods of using antibodies to detect alpha-synuclein in fluid samples
|
|
EP1697741A4
(en)
|
2003-12-04 |
2008-02-13 |
Xencor Inc |
PROCESS FOR PRODUCING PROTEIN VARIANTS WITH INCREASED HOST STRUCTURE CONTENT AND COMPOSITIONS THEREOF
|
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
ES2325931T3
(es)
|
2004-11-10 |
2009-09-24 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
Utilizacion del analisis por citometria de flujo para optimizar las estrategias de almacenamiento en bancos de celulas para celulas cho.
|
|
US20080300204A1
(en)
|
2005-07-19 |
2008-12-04 |
University Of Rochester |
Alpha-Synuclein Antibodies and Methods Related Thereto
|
|
WO2007021255A1
(en)
*
|
2005-08-09 |
2007-02-22 |
Elan Pharmaceuticals, Inc. |
Antibodies to alpha-synuclein
|
|
US8148085B2
(en)
|
2006-05-15 |
2012-04-03 |
Sea Lane Biotechnologies, Llc |
Donor specific antibody libraries
|
|
AU2007275467B2
(en)
|
2006-07-14 |
2013-12-05 |
Ac Immune S.A. |
Humanized antibody against amyloid beta
|
|
US20080124760A1
(en)
|
2006-07-26 |
2008-05-29 |
Barbara Enenkel |
Regulatory Nucleic Acid Elements
|
|
US8147833B2
(en)
|
2007-02-23 |
2012-04-03 |
Neotope Biosciences Limited |
Prevention and treatment of synucleinopathic and amyloidogenic disease
|
|
CN103396489A
(zh)
|
2007-02-23 |
2013-11-20 |
默沙东公司 |
工程改造的抗IL-23p19抗体
|
|
BRPI0808542A2
(pt)
|
2007-03-02 |
2014-08-26 |
Boehringer Ingelheim Pharma |
Aperfeiçoamento de produção de proteína
|
|
US20100260766A1
(en)
|
2007-03-22 |
2010-10-14 |
Arvind Srivastava |
Stable antibody formulations
|
|
EP2644621B1
(en)
|
2007-03-22 |
2017-12-13 |
Genentech, Inc. |
Apoptotic anti-IgE antibodies
|
|
EP2031064A1
(de)
|
2007-08-29 |
2009-03-04 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Verfahren zur Steigerung von Proteintitern
|
|
CN101896163A
(zh)
|
2007-12-21 |
2010-11-24 |
弗·哈夫曼-拉罗切有限公司 |
抗体制剂
|
|
EA028356B1
(ru)
*
|
2007-12-28 |
2017-11-30 |
Протена Байосайенсиз Лимитед |
Лечение и профилактика амилоидоза
|
|
US8309317B2
(en)
|
2008-04-05 |
2012-11-13 |
Single Cell Technology, Inc. |
Method of screening single cells for the production of biologically active agents
|
|
PL2282758T3
(pl)
|
2008-04-29 |
2019-04-30 |
Bioarctic Ab |
Przeciwciała i szczepionki do zastosowania w terapeutycznych i diagnostycznych sposobach dla zaburzeń związanych z alfa-synukleiną
|
|
WO2009141239A1
(en)
|
2008-05-20 |
2009-11-26 |
F. Hoffmann-La Roche Ag |
A pharmaceutical formulation comprising an antibody against ox40l, uses thereof
|
|
US20120276019A1
(en)
|
2008-07-25 |
2012-11-01 |
Diamedica Inc. |
Tissue kallikrein for the treatment of parkinson's disease
|
|
DE102008048129A1
(de)
|
2008-09-20 |
2010-04-22 |
Lfk-Lenkflugkörpersysteme Gmbh |
Flugkörper mit zumindest einem Bremsfallschirm sowie Befestigungsvorrichtung zur Befestigung eines Bremsfallschirms an einem Flugkörper
|
|
KR20110061629A
(ko)
|
2008-09-30 |
2011-06-09 |
아보트 러보러터리즈 |
개선된 항체 라이브러리
|
|
ES2781754T3
(es)
|
2008-11-07 |
2020-09-07 |
Adaptive Biotechnologies Corp |
Métodos para supervisar las condiciones por análisis de secuencia
|
|
JP5810413B2
(ja)
|
2008-12-19 |
2015-11-11 |
バイオジェン インターナショナル ニューロサイエンス ゲーエムベーハー |
ヒト抗アルファシヌクレイン自己抗体
|
|
JP5815521B2
(ja)
|
2009-07-28 |
2015-11-17 |
シャイア ヒューマン ジェネティック セラピーズ インコーポレイテッド |
ゴーシェ病を治療するための組成物および方法
|
|
WO2011025826A1
(en)
|
2009-08-26 |
2011-03-03 |
Research Development Foundation |
Methods for creating antibody libraries
|
|
AR078161A1
(es)
|
2009-09-11 |
2011-10-19 |
Hoffmann La Roche |
Formulaciones farmaceuticas muy concentradas de un anticuerpo anti cd20. uso de la formulacion. metodo de tratamiento.
|
|
US20130116413A1
(en)
|
2009-12-29 |
2013-05-09 |
Dr. Reddy's Laboratories, Inc. |
Purification of proteins
|
|
EP2366714A1
(en)
|
2010-03-03 |
2011-09-21 |
Dr. Rentschler Holding GmbH & Co. KG |
Naturally occuring autoantibodies against alpha-synuclein that inhibit the aggregation and cytotoxicity of alpha-synuclein
|
|
TW201134488A
(en)
|
2010-03-11 |
2011-10-16 |
Ucb Pharma Sa |
PD-1 antibodies
|
|
JP6060073B2
(ja)
|
2010-04-08 |
2017-01-11 |
ジェイエヌ バイオサイエンシーズ エルエルシー |
Ｃｄ１２２に対する抗体
|
|
BR112012030311A2
(pt)
|
2010-06-08 |
2017-01-24 |
Genentech Inc |
anticorpo
|
|
PT2581113T
(pt)
|
2010-06-11 |
2018-07-04 |
Univ Kyushu Nat Univ Corp |
Anticorpo anti-tim-3
|
|
ES2665317T3
(es)
|
2010-07-15 |
2018-04-25 |
Adheron Therapeutics, Inc. |
Anticuerpos humanizados dirigidos contra el dominio EC1 de la cadherina-11 y composiciones y procedimientos relacionados
|
|
JP6023715B2
(ja)
|
2010-10-11 |
2016-11-09 |
アッヴィ・バハマズ・リミテッド |
タンパク質の精製方法
|
|
JP2014511174A
(ja)
*
|
2011-02-07 |
2014-05-15 |
ネオトープ バイオサイエンシーズ リミテッド |
Ａｐｏｅ免疫療法
|
|
WO2012160536A1
(en)
|
2011-05-26 |
2012-11-29 |
Dr Reddy's Laboratories Limited |
Antibody purification
|
|
JP6061922B2
(ja)
|
2011-06-22 |
2017-01-18 |
ザ ジェネラル ホスピタル コーポレイション |
プロテイノパチーの処置方法
|
|
US20130004484A1
(en)
|
2011-06-30 |
2013-01-03 |
Genentech, Inc. |
Anti-c-met antibody formulations
|
|
PE20141568A1
(es)
|
2011-10-28 |
2014-11-21 |
Neotope Biosciences Ltd |
Anticuerpos humanizados que reconocen la alfa-sinucleina
|
|
MY187874A
(en)
|
2011-10-31 |
2021-10-26 |
Genentech Inc |
Antibody formulations
|
|
UA115439C2
(uk)
|
2012-01-27 |
2017-11-10 |
Протена Біосаєнсиз Лімітед |
Гуманізоване антитіло, яке розпізнає альфа-синуклеїн
|
|
MX380701B
(es)
|
2012-08-29 |
2025-03-12 |
Hoffmann La Roche |
Transporte para atravesar la barrera hematoencefalica.
|
|
US8925815B2
(en)
|
2012-09-05 |
2015-01-06 |
Symbol Technologies, Inc. |
Checkout system for and method of preventing a customer-operated accessory reader facing a bagging area from imaging targets on products passed through a clerk-operated workstation to the bagging area
|
|
UA118441C2
(uk)
|
2012-10-08 |
2019-01-25 |
Протена Біосаєнсиз Лімітед |
Антитіло, що розпізнає альфа-синуклеїн
|
|
US10513555B2
(en)
|
2013-07-04 |
2019-12-24 |
Prothena Biosciences Limited |
Antibody formulations and methods
|
|
JP6744856B2
(ja)
|
2014-04-08 |
2020-08-19 |
プロセナ・バイオサイエンシズ・リミテッド |
α−シヌクレインを認識する抗体を含む血液脳関門シャトル
|
|
US10084674B2
(en)
|
2015-09-09 |
2018-09-25 |
International Business Machines Corporation |
Virtual desktop operation and data continuity preservation
|